B
Research Areas
Biography and Research Information
OverviewAI-generated summary
Bobby L. Boyanton's research focuses on infectious diseases, with a particular emphasis on pediatric infections and pharyngitis pathogens. He investigates the impact of non-pharmacological interventions during the SARS-CoV-2 pandemic on pediatric infections, including *Mycoplasma pneumoniae* and respiratory viruses. His work also examines the mitigation strategies for SARS-CoV-2 infection and their association with reduced Group A Streptococcus pharyngitis. Boyanton has published on the seroprevalence of pediatric SARS-CoV-2 in Arkansas and the implementation of pharmacogenomics testing. Additionally, his research includes case reports and literature reviews on topics such as infective endocarditis caused by *Histoplasma capsulatum* and locally acquired malaria in Arkansas. He has a scholarly h-index of 16, with over 1,156 citations across 70 publications. Boyanton collaborates with researchers at the University of Arkansas for Medical Sciences, including Joshua L. Kennedy, Ashton Ingold, Dana Frederick, and J. Craig Forrest.
Metrics
- h-index: 16
- Publications: 73
- Citations: 1,171
Selected Publications
-
Photo Quiz: Persistent dysuria and hematuria in a 9-year-old male (2026)
-
Hospitalizations and Severity of Rhinovirus-Associated Asthma Exacerbations in Children During the Institution of Non-pharmaceutical Interventions (2026)
-
Photo Quiz: A camper with fever, headache, and fatigue (2026)
-
From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma (2025)
-
Genetic characterization of Plasmodium vivax linked to autochthonous malaria transmission in the US (2023) using Illumina AmpliSeq technology: a genetic epidemiology study (2025)
-
Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children (2025)
-
Review: Current Laboratory and Point-of-Care Pharyngitis Diagnostic Testing and Knowledge Gaps (2024)
-
Review: Known, Emerging, and Remerging Pharyngitis Pathogens (2024)
-
Review: Diagnostic Potential for Collaborative Pharyngitis Biomarkers (2024)
-
SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas (2024)
-
<i>NR3C2</i> microdeletions—an underrecognized cause of pseudohypoaldosteronism type 1A: a case report and literature review (2024)
-
Improving Pediatric Clostridioides difficile Testing Practices: Implementation of a 2-Tier Diagnostic Pathway (2023)
-
SARS-CoV-2 Pandemic Non-Pharmacologic Interventions Temporally Associated with Reduced Pediatric Infections Due to <i>Mycoplasma pneumoniae</i> and Co-Infecting Respiratory Viruses in Arkansas (2023)
-
Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced (2023)
-
The Presence of Non-pharmaceutical Interventions Correlates with Decreased Rates of Asthma Exacerbations and RSV infections in Arkansas (2023)
Grants & Funding
Collaboration Network
Top Collaborators
Joshua L. Kennedy
University of Arkansas for Medical Sciences
11 shared publications
In database
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas
- SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
Showing 5 of 11 shared publications
Rachel A. Frenner
Arkansas Children's Hospital (US)
7 shared publications
- SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas
- SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis
- SARS-CoV-2 Prevention Measures Concomitantly Attenuate <i>Methicillin-Resistant Staphylococcus aureus</i> Infection Rates
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced
Showing 5 of 7 shared publications
Ashton Ingold
University of Arkansas for Medical Sciences
7 shared publications
In database
- SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced
- SARS-CoV-2 Pandemic Non-Pharmacologic Interventions Temporally Associated with Reduced Pediatric Infections Due to <i>Mycoplasma pneumoniae</i> and Co-Infecting Respiratory Viruses in Arkansas
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
Showing 5 of 7 shared publications
Susanna Hartzell
5 shared publications
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- The Presence of Non-pharmaceutical Interventions Correlates with Decreased Rates of Asthma Exacerbations and RSV infections in Arkansas
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
- From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma
- Hospitalizations and Severity of Rhinovirus-Associated Asthma Exacerbations in Children During the Institution of Non-pharmaceutical Interventions
Dana Frederick
University of Arkansas for Medical Sciences
5 shared publications
In database
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- The Presence of Non-pharmaceutical Interventions Correlates with Decreased Rates of Asthma Exacerbations and RSV infections in Arkansas
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
- From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma
- Hospitalizations and Severity of Rhinovirus-Associated Asthma Exacerbations in Children During the Institution of Non-pharmaceutical Interventions
Jessica Snowden
University of Arkansas for Medical Sciences
4 shared publications
In database
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- 1710. <i>Clostridioides difficile</i> Bundle Implementation Reduces Unnecessary Testing in Pediatric Patients
Katherine Caid
University of Arkansas for Medical Sciences (US)
4 shared publications
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- The Presence of Non-pharmaceutical Interventions Correlates with Decreased Rates of Asthma Exacerbations and RSV infections in Arkansas
Karl W. Boehme
Winthrop Rockefeller Foundation (US)
3 shared publications
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Seroprevalence of SARS‐CoV‐2 antibodies in front‐line pediatric health care workers
Catherine Kirkpatrick
Arkansas Children's Hospital
3 shared publications
In database
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Seroprevalence of SARS‐CoV‐2 antibodies in front‐line pediatric health care workers
Rachel Frenner
University of Arkansas for Medical Sciences (US)
3 shared publications
- The Presence of Non-pharmaceutical Interventions Correlates with Decreased Rates of Asthma Exacerbations and RSV infections in Arkansas
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
Erin Hathorn
Arkansas Children's Hospital (US)
3 shared publications
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma
- Hospitalizations and Severity of Rhinovirus-Associated Asthma Exacerbations in Children During the Institution of Non-pharmaceutical Interventions
Nathan A. Ledeboer
Medical College of Wisconsin (US)
3 shared publications
- Review: Known, Emerging, and Remerging Pharyngitis Pathogens
- Review: Current Laboratory and Point-of-Care Pharyngitis Diagnostic Testing and Knowledge Gaps
- Review: Diagnostic Potential for Collaborative Pharyngitis Biomarkers
John B.H. Caldwell
3 shared publications
- Review: Known, Emerging, and Remerging Pharyngitis Pathogens
- Review: Current Laboratory and Point-of-Care Pharyngitis Diagnostic Testing and Knowledge Gaps
- Review: Diagnostic Potential for Collaborative Pharyngitis Biomarkers
Shana M. Owens
University of Arkansas for Medical Sciences
2 shared publications
In database
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
Marianne Kouassi
University of Arkansas for Medical Sciences
2 shared publications
In database
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
Similar Researchers
Based on overlapping research topics
Wilton Remigio
Arkansas State University
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Public Health Research
Maxwell Taylor
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Child and Adolescent Health
Kristine Kay
University of Arkansas for Medical Sciences
Microbial infections and disease research
Child and Adolescent Health
Public Health Research
Stephanie Korff
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Child and Adolescent Health
Shahwar Yousuf
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Child and Adolescent Health
Sandra Johnson
University of Arkansas – Fort Smith
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Public Health Research